Macrobid (Page 4 of 4)
OVERDOSAGE:
Occasional incidents of acute overdosage of nitrofurantoin have not resulted in any specific symptoms other than vomiting. Induction of emesis is recommended. There is no specific antidote, but a high fluid intake should be maintained to promote urinary excretion of the drug. Nitrofurantoin is dialyzable.
DOSAGE AND ADMINISTRATION:
Macrobid capsules should be taken with food.
Adults and Pediatric Patients Over 12 Years: One 100 mg capsule every 12 hours for seven days.
HOW SUPPLIED:
Macrobid is available as 100 mg opaque black and yellow capsules imprinted “Macrobid” on one half and “Norwich Eaton” on the other.
NDC 0149-0710-01 bottle of 100
Store at controlled room temperature (59° to 86°F or 15° to 30°C).
Meets USP Dissolution Test 2
Rx Only
REFERENCES:
- National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard – 5th Edition. Approved Standard NCCLS Document M7-A5. NCCLS: Wayne, PA; 2003.
- National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard – 8th Edition. Approved Standard NCCLS Document M2-A7. NCCLS: Wayne, PA; 2003.
CLINICAL STUDIES:
Controlled clinical trials comparing Macrobid 100 mg p.o. q12h and Macrodantin 50 mg p.o. q6h in the treatment of acute uncomplicated urinary tract infections demonstrated approximately 75% microbiologic eradication of susceptible pathogens in each treatment group.
Mfg. By: Norwich Pharmaceuticals, Inc.
North Norwich, NY 13814
Dist. by: Procter & Gamble Pharmaceuticals, Inc.,
TM Owner, Cincinnati, OH 45202
REVISED January 2009
MACROBID nitrofurantoin monohydrate and nitrofurantoin, macrocrystalline capsule | ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
Labeler — Procter and Gamble Pharmaceuticals, Inc. |
Revised: 03/2009 Procter and Gamble Pharmaceuticals, Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.